Teva completes acquisition of Auspex Pharmaceuticals
MLex Summary: Teva Pharmaceutical Industries said that the company has successfully completed its planned $3.2 billion acquisition of movement disorder drug developer Auspex Pharmaceuticals.Statement follows in full....To view the full article, register now.
Already a subscriber? Click here to view full article